Shimadzu logo

Shimadzu

Asia, Kyoto, Japan, Kyoto

Description

Shimadzu is pursuing leading-edge science and technologies in analytical and measuring instruments including chromatographs.

Investor Profile

Shimadzu has made 3 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Series B (33%)

Country Focus

  • Japan (67%)
  • Canada (33%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Medical
  • Rental
  • Chemical
  • Industrial Automation
  • Industrial Manufacturing
  • Oil And Gas
  • Pharmaceutical
  • Predictive Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shimadzu frequently co-invest with?

Kyogin Lease & Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Asahi Kasei Corporate Venture Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Global Brain Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
CV
Asia, Kyoto, Japan, Kyoto
Co-Investments: 2
DM Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Kyoto University Innovation Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 2
Healthcare Innovation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
M3
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Shimadzu?

Basetwo AI

Toronto, Ontario, Canada

Basetwo is an AI CoPilot for manufacturing that provides engineers with recommendations on how to optimize yield, quality, and costs.

ChemicalIndustrial AutomationIndustrial ManufacturingManufacturingOil and GasPharmaceuticalPredictive AnalyticsSoftware
Series AJan 23, 2025
Amount Raised: $11,473,352
Rege Nephro

Kyoto, Kyoto, Japan

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

BiotechnologyManufacturingMedicalRental
Series BOct 7, 2024
Amount Raised: $15,189,217
Rege Nephro

Kyoto, Kyoto, Japan

Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.

BiotechnologyManufacturingMedicalRental
Series AJan 31, 2022